BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31665359)

  • 21. New Verapamil Analogs Inhibit Intracellular Mycobacteria without Affecting the Functions of Mycobacterium-Specific T Cells.
    Abate G; Ruminiski PG; Kumar M; Singh K; Hamzabegovic F; Hoft DF; Eickhoff CS; Selimovic A; Campbell M; Chibale K
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1216-25. PubMed ID: 26643325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of an in vitro model using NR8383 cells and Mycobacterium bovis Calmette-Guerin that mimics a chronic infection of Mycobacterium tuberculosis.
    Hino M; Oda M; Yoshida A; Nakata K; Kohchi C; Nishizawa T; Inagawa H; Hori H; Makino K; Terada H; Soma G
    In Vivo; 2005; 19(5):821-30. PubMed ID: 16097433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Virulent Mycobacterium tuberculosis and HIV Coinfected Macrophages with Gallium Nanoparticles Inhibits Pathogen Growth and Modulates Macrophage Cytokine Production.
    Choi SR; Britigan BE; Narayanasamy P
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31341073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ex vivo production of interferon-gamma, tumor necrosis factor-alpha, and interleukin-6 by mouse macrophages during infection with M. bovis and M. tuberculosis H37Rv.
    Chernousova LN; Smirnova TG; Afanasieva EG; Karpov VL; Timofeev AV
    Bull Exp Biol Med; 2007 Nov; 144(5):709-12. PubMed ID: 18683503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
    Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
    Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small Molecule Mediated Restoration of Mitochondrial Function Augments Anti-Mycobacterial Activity of Human Macrophages Subjected to Cholesterol Induced Asymptomatic Dyslipidemia.
    Asalla S; Mohareer K; Banerjee S
    Front Cell Infect Microbiol; 2017; 7():439. PubMed ID: 29067283
    [No Abstract]   [Full Text] [Related]  

  • 27. Coadministration of interleukins 7 and 15 with bacille Calmette-Guérin mounts enduring T cell memory response against Mycobacterium tuberculosis.
    Singh V; Gowthaman U; Jain S; Parihar P; Banskar S; Gupta P; Gupta UD; Agrewala JN
    J Infect Dis; 2010 Aug; 202(3):480-9. PubMed ID: 20569158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide.
    Sun Z; Zhang Y
    Antimicrob Agents Chemother; 1999 Mar; 43(3):537-42. PubMed ID: 10049264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymoquinone (TQ) inhibits the replication of intracellular Mycobacterium tuberculosis in macrophages and modulates nitric oxide production.
    Mahmud HA; Seo H; Kim S; Islam MI; Nam KW; Cho HD; Song HY
    BMC Complement Altern Med; 2017 May; 17(1):279. PubMed ID: 28545436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PE17 protein from Mycobacterium tuberculosis enhances Mycobacterium smegmatis survival in macrophages and pathogenicity in mice.
    Li Z; Liu H; Li H; Dang G; Cui Z; Song N; Wang Q; Liu S; Chen L
    Microb Pathog; 2019 Jan; 126():63-73. PubMed ID: 30366126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycobacterium tuberculosis PPE25 and PPE26 proteins expressed in Mycobacterium smegmatis modulate cytokine secretion in mouse macrophages and enhance mycobacterial survival.
    Mi Y; Bao L; Gu D; Luo T; Sun C; Yang G
    Res Microbiol; 2017 Apr; 168(3):234-243. PubMed ID: 27351106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Layer-by-layer nanocoating of live Bacille-Calmette-Guérin mycobacteria with poly(I:C) and chitosan enhances pro-inflammatory activation and bactericidal capacity in murine macrophages.
    Speth MT; Repnik U; Griffiths G
    Biomaterials; 2016 Dec; 111():1-12. PubMed ID: 27716523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron modulates the replication of virulent Mycobacterium bovis in resting and activated bovine and possum macrophages.
    Denis M; Buddle BM
    Vet Immunol Immunopathol; 2005 Sep; 107(3-4):189-99. PubMed ID: 15993492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
    Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination with Bacille-Calmette Guérin promotes mycobacterial control in guinea pig macrophages infected in vivo.
    Ly LH; Barhoumi R; Cho SH; Franzblau SG; McMurray DN
    J Infect Dis; 2008 Sep; 198(5):768-71. PubMed ID: 18627245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential TLR2 downstream signaling regulates lipid metabolism and cytokine production triggered by Mycobacterium bovis BCG infection.
    Almeida PE; Roque NR; Magalhães KG; Mattos KA; Teixeira L; Maya-Monteiro C; Almeida CJ; Castro-Faria-Neto HC; Ryffel B; Quesniaux VF; Bozza PT
    Biochim Biophys Acta; 2014 Jan; 1841(1):97-107. PubMed ID: 24120921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitubercular activity of new coumarins.
    Cardoso SH; Barreto MB; Lourenço MC; Henriques Md; Candéa AL; Kaiser CR; de Souza MV
    Chem Biol Drug Des; 2011 Jun; 77(6):489-93. PubMed ID: 21414146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate cytokine profiling of bovine alveolar macrophages reveals commonalities and divergence in the response to Mycobacterium bovis and Mycobacterium tuberculosis infection.
    Magee DA; Conlon KM; Nalpas NC; Browne JA; Pirson C; Healy C; McLoughlin KE; Chen J; Vordermeier HM; Gormley E; MacHugh DE; Gordon SV
    Tuberculosis (Edinb); 2014 Jul; 94(4):441-50. PubMed ID: 24882682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimation of pyrazinamidase activity using a cell-free
    Rueda D; Bernard C; Gandy L; Capton E; Boudjelloul R; Brossier F; Veziris N; Zimic M; Sougakoff W
    Int J Mycobacteriol; 2018; 7(1):16-25. PubMed ID: 29516881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.